Low oxygen levels can be a sign that a patient is in danger. A device that measures oxygen levels has been shown to miss low oxygen...
AstraZeneca Plc's cancer drug Imfinzi was approved in Europe and Britain for a spaced-out regimen in a common type of lung cancer to help reduce the...
South Korea’s Celltrion has announced encouraging top-line results for its potential antibody therapy for COVID-19, with the first The post Celltrion closes in on COVID-19 antibody...
NextCure has found its new CMO after the previous executive resigned last August. Han Myint, a biopharma and academia veteran of more than 20 years, joined...
In the first episode of GEN Live for 2021, we’ll survey the state of biotech in 2021, relive some key moments in GEN’s first 40 years,...
In this second ‘Nine for 2021‘ article, IQVIA’s Sarah Rickwood looks at four issues which will directly impact The post Nine for 2021: Addressing the pandemic...
Last year, I published a paper that showed that cancer mortality rates fell by 24% between 2000 and 2016 and further that new cancer drugs accounted...
Sana Biotechnology is one of those startups that was sketched in on the chalkboard day one in the shape of a unicorn. A giant unicorn. And...
'Orphan drugs' with high price points are being tested as treatments for COVID-19. There's a better way to spur low-cost innovation for new drugs.
BioSpace looks at some of the top stories from Day 2 of the virtual JP Morgan Annual Healthcare Conference.
Credit: Cody Duty/UTHealth Researchers evaluating whether an investigational oral drug, vadadustat, can help prevent acute respiratory distress syndrome (ARDS) in COVID-19 patients were awarded $5.1 million...
Spike in evacuations for heart conditions Credit: Royal Flying Doctor Service New data released this week by Australian researchers reveals the impact of the COVID-19 lockdown...
Regeneron Pharmaceuticals has signed an agreement with the U.S. for the additional supply of 1.25 million doses of its antibody cocktail for the use in non-hospitalized...
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical The post Coordinating and delivering research in the...
CNBC Exclusive: CNBC Transcript: Pfizer Chairman and CEO Albert Bourla speaks with CNBC’s “Squawk Box” today about the Covid vaccine manufacturing outlook. Q3 2020 hedge fund...
Despite some controversy over the effectiveness of Gilead Sciences’ Veklury (remdesivir), the product is bolstering the company’s bottom line.
With a new year comes the opportunity to think ahead for the market access landscape for the coming The post 2021 – UK market access prospects...
The study was carried out with data from 89 patients admitted to the IFEMA Hospital Credit: CNIO Patients with severe COVID-19 disease have significantly shorter telomeres,...
CNBC Exclusive: CNBC Transcript: Gilead Sciences Chairman & CEO Daniel O’Day speaks with CNBC’s “Squawk Box” today about raising full-year guidance due to remdesivir sales. Q3...
How resistance to drugs originates, and why it's different for vaccines.
Children's Hospitals Grapple With Wave Of Mental Illness Authored by Carmen Heredia Rodriguez via Kaiser Health News, Krissy Williams, 15, had attempted suicide before, but never...
Iain Brown → Vowing to find a groove after a string of bogeys on the scorecard, Richard Pops has shaken up the C-suite at Alkermes, staying...
Hooking up with a stranger is against the law under lockdown, so more people are going online for their thrills.
A little less than two years after bagging an extended $50 million Series C, IsoPlexis and its “proteomic barcodes” for personalized cancer care are back setting...
Synthetic biology has become a powerful tool to advance science, making processes more efficient, enabling completely new approaches to biology, and helping scientists find the right...
New solutions in biomedical research are propelling the field by leaps and bounds ahead of what was accomplished in decades past. Biotechnology and particularly genome engineering...
COVID-19 has compressed bioprocessing timelines, leaving no room for uncertainty in the characterization of raw materials and contaminants. The post Bioprocessing in a Post-COVID-19 World appeared...
To present to our readers a timely take on agbiotech, GEN spoke with two experts who represent Yield10 Bioscience, an agricultural bioscience company that is working...
Legendary scientist Leroy Hood describes how he has applied systems thinking to realize many interdisciplinary initiatives that are now culminating in the development of 21st century...
While biopharma was dominated by COVID-19, which prompted a surge of research and business activity, the industry also saw developments that will position it for further...